Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer.
Bast
R C
RC
Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, North Carolina.
Xu
F
F
Yu
Y
Y
Crews
J
J
Argon
Y
Y
Maier
L
L
Lidor
Y
Y
Berchuck
A
A
Boyer
C M
CM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D001943:Breast Neoplasms / Q000276:immunology* / Q000628:therapy; D066246:ErbB Receptors / Q000032:analysis / Q000276:immunology; D005260:Female; D006801:Humans; D000922:Immunotoxins / Q000494:pharmacology*; D051379:Mice; D010051:Ovarian Neoplasms / Q000276:immunology* / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000276:immunology; D018719:Erb-b2 Receptor Tyrosine Kinases
D000911:Antibodies, Monoclonal; D066246:ErbB Receptors; D000922:Immunotoxins; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases